BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 10649246)

  • 1. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
    Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
    Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
    Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
    Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
    Folpe AL; Gown AM; Lamps LW; Garcia R; Dail DH; Zarbo RJ; Schmidt RA
    Mod Pathol; 1999 Jan; 12(1):5-8. PubMed ID: 9950155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.
    Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
    Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
    Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic findings of bronchial brush cytology for pulmonary large cell neuroendocrine carcinomas: comparison with poorly differentiated adenocarcinomas, squamous cell carcinomas, and small cell carcinomas.
    Kakinuma H; Mikami T; Iwabuchi K; Yokoyama M; Hattori M; Ohno E; Kuramoto H; Jiang SX; Okayasu I
    Cancer; 2003 Aug; 99(4):247-54. PubMed ID: 12925987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length, telomerase activity, and expressions of human telomerase mRNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA in pulmonary neuroendocrine tumors.
    Nishio Y; Nakanishi K; Ozeki Y; Jiang SX; Kameya T; Hebisawa A; Mukai M; Travis WD; Franks TJ; Kawai T
    Jpn J Clin Oncol; 2007 Jan; 37(1):16-22. PubMed ID: 17060405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.
    Marchetti A; Felicioni L; Pelosi G; Del Grammastro M; Fumagalli C; Sciarrotta M; Malatesta S; Chella A; Barassi F; Mucilli F; Camplese P; D'Antuono T; Sacco R; Buttitta F
    Hum Mutat; 2008 May; 29(5):609-16. PubMed ID: 18293376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
    Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
    Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression of P16 and Rb proteins in 106 cases of lung cancer].
    Qin J; Chen G; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Oct; 23(10):588-90. PubMed ID: 11372380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RB growth control evasion in lung cancer.
    Caputi M; Esposito V; Groger AM; De Luca A; Pacilio C; Dekan G; Giordano GG; Baldi F; Wolner E; Giordano A
    Anticancer Res; 1998; 18(4A):2371-4. PubMed ID: 9703881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of microRNA miR-21, miR-155, and let-7a and their roles in pulmonary neuroendocrine tumors.
    Lee HW; Lee EH; Ha SY; Lee CH; Chang HK; Chang S; Kwon KY; Hwang IS; Roh MS; Seo JW
    Pathol Int; 2012 Sep; 62(9):583-91. PubMed ID: 22924844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications.
    Cagle PT; el-Naggar AK; Xu HJ; Hu SX; Benedict WF
    Am J Pathol; 1997 Feb; 150(2):393-400. PubMed ID: 9033254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
    Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
    Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
    Suzuki H; Sugimura H; Hashimoto K
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
    Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL
    J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.